Table 2.
Characteristics | Sertraline (n = 49) | Placebo (n = 46) | Overall (n = 95) | P Value |
---|---|---|---|---|
HTR2A, % | .3440 | |||
Missing | 0 | 4.3 | 2.1 | |
CC | 34.7 | 30.4 | 32.6 | |
CT | 46.9 | 56.5 | 51.6 | |
TT | 18.4 | 8.7 | 13.7 | |
HTR2C, % | .8949 | |||
AA | 65.3 | 69.6 | 67.4 | |
AC | 18.4 | 15.2 | 16.8 | |
CC | 16.3 | 15.2 | 15.8 | |
HTT-LPR, % | .9395 | |||
LL | 34.7 | 37.0 | 35.8 | |
SL | 44.9 | 41.3 | 43.2 | |
SS | 20.4 | 21.7 | 21.1 | |
BDNF, % | .3732 | |||
AA | 0 | 2.2 | 1.1 | |
GA | 26.5 | 34.8 | 30.5 | |
GG | 63.5 | 63.0 | 68.4 |